The pharmacokinetic profile of standard and low-dose OKT3 induction immunosuppression in renal transplant recipients

Transplantation. 1994 Jul 27;58(2):249-53.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • CD3 Complex / analysis
  • Double-Blind Method
  • Female
  • Half-Life
  • Humans
  • Immunosuppression
  • Kidney / metabolism*
  • Kidney Transplantation*
  • Kinetics
  • Male
  • Muromonab-CD3 / administration & dosage*

Substances

  • CD3 Complex
  • Muromonab-CD3